APRIL LENZ: Open Payments
NPI 1538731724 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,548 in 147 payments from 29 companies in 2025. Trend: 2023 $2,459 · 2024 $3,351 · 2025 $2,548
Food & beverage: $2,548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 26 | $398 |
| ABBVIE INC. | 21 | $318 |
| AstraZeneca Pharmaceuticals LP | 8 | $278 |
| Lilly USA, LLC | 15 | $248 |
| PFIZER INC. | 15 | $146 |
| Almatica Pharma LLC | 5 | $106 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| Exact Sciences Corporation | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
Products named: AIRSUPRA, Ozempic, JARDIANCE, VRAYLAR, Wegovy, NURTEC ODT, MOUNJARO, LOREEV XR.
Industry payments across OH — which companies pay providers there.
